Cargando…

Fluoroquinolone toxicity symptoms in a patient presenting with low back pain

Fluoroquinolone medications have been shown to contribute to tendinopathies, cardiotoxicity, and neurotoxicity. Low back pain is a common musculoskeletal condition for which chiropractic treatment is most often sought. This case report details a patient presenting with low back pain and a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauchman, Megan, Morningstar, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981197/
https://www.ncbi.nlm.nih.gov/pubmed/24765486
http://dx.doi.org/10.4081/cp.2012.e87
_version_ 1782310993957748736
author Strauchman, Megan
Morningstar, Mark W.
author_facet Strauchman, Megan
Morningstar, Mark W.
author_sort Strauchman, Megan
collection PubMed
description Fluoroquinolone medications have been shown to contribute to tendinopathies, cardiotoxicity, and neurotoxicity. Low back pain is a common musculoskeletal condition for which chiropractic treatment is most often sought. This case report details a patient presenting with low back pain and a history of fluoroquinolone toxicity. The patient was initially treated with chiropractic manipulation, which increased her symptoms. She was then referred to an osteopathic physician who treated the patient with intravenous antioxidants and amino acids, an elimination diet, and probiotic supplementation. Within 4 months of therapy, the patient reported a decrease in pain, a resolution of her dizziness, shortness of breath, panic attacks, tachycardia, and blurred vision. After an additional 8 weeks of antioxidant therapy, she reported further reductions in pain and improved disability. People susceptible to fluoroquinolone toxicity may present with common musculoskeletal symptoms. A past medical history and medication history may help to identify this population of patients. People presenting with fluoroquinolone toxicity may have unidentified contributing factors that predispose them to this anomaly. This patient reported improvements in pain and disability following antioxidant amino acid therapy for a total of 6 months. The natural history of fluoroquinolone toxicity is unknown and may account for the observed improvements.
format Online
Article
Text
id pubmed-3981197
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-39811972014-04-24 Fluoroquinolone toxicity symptoms in a patient presenting with low back pain Strauchman, Megan Morningstar, Mark W. Clin Pract Case Report Fluoroquinolone medications have been shown to contribute to tendinopathies, cardiotoxicity, and neurotoxicity. Low back pain is a common musculoskeletal condition for which chiropractic treatment is most often sought. This case report details a patient presenting with low back pain and a history of fluoroquinolone toxicity. The patient was initially treated with chiropractic manipulation, which increased her symptoms. She was then referred to an osteopathic physician who treated the patient with intravenous antioxidants and amino acids, an elimination diet, and probiotic supplementation. Within 4 months of therapy, the patient reported a decrease in pain, a resolution of her dizziness, shortness of breath, panic attacks, tachycardia, and blurred vision. After an additional 8 weeks of antioxidant therapy, she reported further reductions in pain and improved disability. People susceptible to fluoroquinolone toxicity may present with common musculoskeletal symptoms. A past medical history and medication history may help to identify this population of patients. People presenting with fluoroquinolone toxicity may have unidentified contributing factors that predispose them to this anomaly. This patient reported improvements in pain and disability following antioxidant amino acid therapy for a total of 6 months. The natural history of fluoroquinolone toxicity is unknown and may account for the observed improvements. PAGEPress Publications 2012-11-28 /pmc/articles/PMC3981197/ /pubmed/24765486 http://dx.doi.org/10.4081/cp.2012.e87 Text en ©Copyright M. Strauchman and M.W. Morningstar, 2012 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Strauchman, Megan
Morningstar, Mark W.
Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title_full Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title_fullStr Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title_full_unstemmed Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title_short Fluoroquinolone toxicity symptoms in a patient presenting with low back pain
title_sort fluoroquinolone toxicity symptoms in a patient presenting with low back pain
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981197/
https://www.ncbi.nlm.nih.gov/pubmed/24765486
http://dx.doi.org/10.4081/cp.2012.e87
work_keys_str_mv AT strauchmanmegan fluoroquinolonetoxicitysymptomsinapatientpresentingwithlowbackpain
AT morningstarmarkw fluoroquinolonetoxicitysymptomsinapatientpresentingwithlowbackpain